Africa Active Pharmaceutical Ingredients (API) Market Outlook (2014-2022)

September 2015 | 84 pages | ID: AEB15173B51EN
Stratistics Market Research Consulting

Abstracts

The “Africa Active Pharmaceutical Ingredients (API) Market” report provides an in-depth analysis of the various market segments and its sub-segments. The Active Pharmaceutical Ingredients (API) market is segmented on the basis of type of API, manufacturers, therapeutic area and geography. On the basis of type of API, the active pharmaceutical ingredients market is segmented into synthetic chemical API and biological API. By type of manufacturers, the market is categorized into captive (or in-house) and contract manufacturing. By therapeutic applications, the market is segmented into oncology, anti-Infectives, cardiovascular and hematopoietic system, gastrointestinal disorder, hormonal-related disorder, metabolic disorder, musculo-skeletal disorder and others. Based on the geography the market is categorized into Egypt, South Africa, Nigeria and Rest of Africa.

The report focuses on current and upcoming market trends such as Drivers, Constraints, Opportunities, and Challenges, technological advancements, Porters Five Forces analysis to assess the intensity of competition in the market. The market values are presented in the form of tables and graphs for better interpretation.

Market Size Estimations

The market assessment is made by the core industry experts using our 360° research approach. The data is derived from the most reliable, authenticated data sources and is validated by the industry experts (Primary Research). Both top down and bottom up analysis are implemented to enhance the accuracy of the market figures. The market projections are calculated for the next 8 years using the actual market numbers of previous year as the base year.

Company Profiling

This section provides the overview of the key players that are leading in the industry, covering their business operations, financials, list of products & services, SWOT analysis, major developments such as mergers & acquisitions, agreements, partnerships, joint ventures, new product launch, expansions etc.

Report Highlights:

• Market share assessments for all the mentioned market segments and sub-segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 8 years for all the given segments
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping, mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPES OF API

5.1 Introduction
5.2 Synthetic chemical API
5.3 Biological API

6 AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURING

6.1 Introduction
6.2 Captive (or in-house) manufacturing
6.3 Contract manufacturing

7 AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATIONS

7.1 Introduction
7.2 Oncology
7.3 Anti-Infectives
7.4 Cardiovascular and hematopoietic system
7.5 Gastrointestinal disorder
7.6 Hormonal-related disorder
7.7 Metabolic disorder
7.8 Musculo-skeletal disorder

8 AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY GEOGRAPHY

8.1 Africa
  8.1.1 Egypt
  8.1.2 South Africa
  8.1.3 Nigeria
  8.1.4 Rest of Africa

9 KEY DEVELOPMENTS

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 COMPANY PROFILING

10.1 Zoetis (U.S.)
10.2 Merck Animal Health (U.S.)
10.3 Merial Inc. (Sanofi) (France)
10.4 Elanco Animal Health (U.S.)
10.5 Boehringer Ingelheim (Germany)
10.6 Bayer Healthcare (Germany)
10.7 Bioniche Animal Health (South Africa)
10.8 Heska Co. (U.S.)
10.9 Ceva Animal Health, Inc.
10.10 Virbac

List Of Tables

LIST OF TABLES

1 Africa Chemical Seed treatment Market, By Countries (2012-2022) ($MN)
2 Africa Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
3 Egypt Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
4 South Africa Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
5 Nigeria Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
6 Rest of Africa Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
7 Africa Active Pharmaceutical Ingredients Market, By Synthetic chemical API (2012-2022) ($MN)
8 Africa Active Pharmaceutical Ingredients Market, By Biological API (2012-2022) ($MN)
9 Africa Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
10 Egypt Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
11 South Africa Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
12 Nigeria Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
13 Rest of Africa Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
14 Africa Active Pharmaceutical Ingredients Market, By Captive (or in-house) manufacturing (2012-2022) ($MN)
15 Africa Active Pharmaceutical Ingredients Market, By Contract manufacturing (2012-2022) ($MN)
16 Africa Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
17 Egypt Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
18 South Africa Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
19 Nigeria Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
20 Rest of Africa Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
21 Africa Active Pharmaceutical Ingredients Market, By Oncology (2012-2022) ($MN)
22 Africa Active Pharmaceutical Ingredients Market, By Anti-Infectives (2012-2022) ($MN)
23 Africa Active Pharmaceutical Ingredients Market, By Cardiovascular and hematopoietic system (2012-2022) ($MN)
24 Africa Active Pharmaceutical Ingredients Market, By Gastrointestinal disorder (2012-2022) ($MN)
25 Africa Active Pharmaceutical Ingredients Market, By Hormonal-related disorder (2012-2022) ($MN)
26 Africa Active Pharmaceutical Ingredients Market, By Metabolic disorder (2012-2022) ($MN)
27 Africa Active Pharmaceutical Ingredients Market, By Musculo-skeletal disorder (2012-2022) ($MN)